Traumatic Brain Injury Unlocks Musical Prodigy; Long COVID Treatment Advances; Delirium’s Link to Dementia Risk

The New York Times chronicled the remarkable case of Edward Freytag, who developed extraordinary musical abilities following a traumatic brain injury. Meanwhile, Bright Minds Biosciences disclosed that the FDA has imposed a partial clinical hold on its investigational compound BMB-101, pending further safety data.

Source link